Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

HEADACHE

Disentangling placebo effects in the treatment of migraine

Nature Reviews Neurology volume 16, pages 657–658 (2020)Cite this article

Subjects

A new meta-analysis of placebo-controlled trials of calcitonin gene-related peptide (CGRP) antibodies for migraine has shown that the direct biological effects of these treatments beyond the effects of placebo are modest, raising questions about how the ‘true value’ of these and other drugs are assessed.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kaptchuk, T. J., Hemond, C. C. & Miller, F. G. Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice. BMJ 370, m1668 (2020).

    Article  Google Scholar 

  2. Forbes, R. B., McCarron, M. & Cardwell, C. R. Efficacy and contextual (placebo) effects of CGRP antibodies for migraine: systematic review and meta-analysis. Headache https://doi.org/10.1111/head.13907 (2020).

    Article  PubMed  Google Scholar 

  3. Turner, J. A., Deyo, R. A., Loeser, J. D., Von Korff, M. & Fordyce, W. E. The importance of placebo effects in pain treatment and research. JAMA 271, 1609–1614 (1994).

    Article  CAS  Google Scholar 

  4. McDonald, C. J., Mazzuca, S. A. & McCabe, G. P. Jr. How much of the placebo ‘effect’ is really statistical regression? Stat. Med. 2, 417–427 (1983).

    Article  CAS  Google Scholar 

  5. Westreich, D. & Mooney, S. J. Number (of whom?) needed to treat (with what?): exposures, population interventions and the number needed to treat. Epidemiology 30 (Suppl. 2), S55–S59 (2019).

    Article  Google Scholar 

  6. McRae, C. et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch. Gen. Psychiatry 61, 412–420 (2004).

    Article  Google Scholar 

  7. Kelley, J. M. Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology 85, 742–743 (2015).

    Article  Google Scholar 

  8. Xu, S. et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ 368, m697 (2020).

    Article  Google Scholar 

  9. Kam-Hansen, S. et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci. Transl Med. 6, 218ra5 (2014).

    Article  Google Scholar 

  10. Schwedt, T. J., Hentz, J. G. & Dodick, D. W. Factors associated with the prophylactic effect of placebo injections in subjects enrolled in a study of botulinum toxin for migraine. Cephalalgia 27, 528–534 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Elizabeth W. Loder & Brian McGeeney

  2. Harvard Medical School, Boston, MA, USA

    Elizabeth W. Loder & Brian McGeeney

  3. Graham Headache Center, Brigham and Women’s Faulkner Hospital, Boston, MA, USA

    Elizabeth W. Loder & Brian McGeeney

Authors
  1. Elizabeth W. Loder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian McGeeney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth W. Loder.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Loder, E.W., McGeeney, B. Disentangling placebo effects in the treatment of migraine. Nat Rev Neurol 16, 657–658 (2020). https://doi.org/10.1038/s41582-020-0406-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-020-0406-7

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing